Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Prevalence of spondyloarthritis in Turkish patients with inflammatory bowel disease.

Beslek A, Onen F, Birlik M, Akarsu M, Akar S, Sari I, Gurler O, Akpinar H, Manisali M, Akkoc N.

Rheumatol Int. 2009 Jun;29(8):955-7. doi: 10.1007/s00296-008-0811-5. Epub 2008 Dec 10.

PMID:
19082597
2.

Prevalence of self-reported spondyloarthritis features in a cohort of patients with inflammatory bowel disease.

Stolwijk C, Pierik M, Landewé R, Masclee A, van Tubergen A.

Can J Gastroenterol. 2013 Apr;27(4):199-205.

4.

The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease.

Turkcapar N, Toruner M, Soykan I, Aydintug OT, Cetinkaya H, Duzgun N, Ozden A, Duman M.

Rheumatol Int. 2006 May;26(7):663-8. Epub 2005 Sep 1.

PMID:
16136311
5.

[The prevalence of radiographic sacroiliitis in patients affected by inflammatory bowel disease with inflammatory low back pain].

Podswiadek M, Punzi L, Stramare R, D'Incà R, Ferronato A, Lo Nigro A, Sturniolo GC.

Reumatismo. 2004 Apr-Jun;56(2):110-3. Italian.

6.

High frequency of inflammatory back pain and other features of spondyloarthritis in patients with rheumatoid arthritis.

Can G, Solmaz D, Binicier O, Akar S, Birlik M, Soysal O, Akkoc N, Manisali M, Onen F.

Rheumatol Int. 2013 May;33(5):1289-93. doi: 10.1007/s00296-012-2553-7. Epub 2012 Nov 6.

PMID:
23129430
7.

Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association.

de Vlam K, Mielants H, Cuvelier C, De Keyser F, Veys EM, De Vos M.

J Rheumatol. 2000 Dec;27(12):2860-5.

PMID:
11128677
8.

Extraintestinal manifestations in inflammatory bowel disease: Prevalence and predictors in Indian patients.

Bandyopadhyay D, Bandyopadhyay S, Ghosh P, De A, Bhattacharya A, Dhali GK, Das K.

Indian J Gastroenterol. 2015 Sep;34(5):387-94. doi: 10.1007/s12664-015-0598-8. Epub 2015 Nov 28.

PMID:
26614005
9.

[Enteropathic spondylarthritis in chronic inflammatory bowel diseases: prevalence, manifestation pattern and HLA association].

Protzer U, Duchmann R, Höhler T, Hitzler W, Ewe K, Wanitschke R, Meyer zum Büschenfelde KH, Märker-Hermann E.

Med Klin (Munich). 1996 Jun 15;91(6):330-5. German.

PMID:
8767304
10.

Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.

Malaviya AN, Kalyani A, Rawat R, Gogia SB.

Int J Rheum Dis. 2015 Sep;18(7):736-41. doi: 10.1111/1756-185X.12579. Epub 2015 Jul 14.

PMID:
26172961
11.

Management of patients with inflammatory bowel disease and spondyloarthritis.

Pouillon L, Bossuyt P, Vanderstukken J, Moulin D, Netter P, Danese S, Jouzeau JY, Loeuille D, Peyrin-Biroulet L.

Expert Rev Clin Pharmacol. 2017 Dec;10(12):1363-1374. doi: 10.1080/17512433.2017.1377609. Epub 2017 Sep 20. Review.

PMID:
28879780
12.

Prevalence of spondyloarthritis symptom in inflammatory bowel disease patients: A questionnaire survey.

Kamo K, Shuto T, Haraguchi A.

Mod Rheumatol. 2015 May;25(3):435-7. doi: 10.3109/14397595.2014.964925. Epub 2014 Nov 10.

PMID:
25381725
13.

Ultrasound discloses entheseal involvement in inactive and low active inflammatory bowel disease without clinical signs and symptoms of spondyloarthropathy.

Bandinelli F, Milla M, Genise S, Giovannini L, Bagnoli S, Candelieri A, Collaku L, Biagini S, Cerinic MM.

Rheumatology (Oxford). 2011 Jul;50(7):1275-9. doi: 10.1093/rheumatology/keq447. Epub 2011 Feb 10.

PMID:
21317135
14.

[Immune-mediated inflammatory diseases in patients with inflammatory bowel disease. Baseline data from the Aquiles study].

Marín-Jiménez I, García Sánchez V, Gisbert JP, Lázaro Pérez Calle J, Luján M, Gordillo Ábalos J, Tabernero S, Juliá B, Romero C, Cea-Calvo L, García-Vicuña R, Vanaclocha F.

Gastroenterol Hepatol. 2014 Nov;37(9):495-502. doi: 10.1016/j.gastrohep.2014.02.010. Epub 2014 Apr 8. Spanish.

PMID:
24717523
15.

Development of inflammatory bowel disease during anti-TNF-α therapy for inflammatory rheumatic disease: a nationwide series.

Toussirot É, Houvenagel É, Goëb V, Fouache D, Martin A, Le Dantec P, Dernis E, Wendling D, Ansemant T, Berthelot JM, Bader-Meunier B, Kantelip B; Le CRI.

Joint Bone Spine. 2012 Oct;79(5):457-63. doi: 10.1016/j.jbspin.2011.10.001. Epub 2011 Nov 15.

PMID:
22088934
16.

Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China.

Jiang L, Xia B, Li J, Ye M, Yan W, Deng C, Ding Y, Luo H, Hou W, Zhao Q, Liu N, Ren H, Hou X, Xu H.

Inflamm Bowel Dis. 2006 Mar;12(3):212-7.

PMID:
16534423
17.

Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort.

Vavricka SR, Brun L, Ballabeni P, Pittet V, Prinz Vavricka BM, Zeitz J, Rogler G, Schoepfer AM.

Am J Gastroenterol. 2011 Jan;106(1):110-9. doi: 10.1038/ajg.2010.343. Epub 2010 Aug 31.

PMID:
20808297
18.

Spondyloarthropathy in inflammatory bowel disease patients on TNF inhibitors.

Subramaniam K, Tymms K, Shadbolt B, Pavli P.

Intern Med J. 2015 Nov;45(11):1154-60. doi: 10.1111/imj.12891.

PMID:
26337851
19.

Occult radiological sacroiliac abnormalities in patients with inflammatory bowel disease who do not present signs or symptoms of axial spondylitis.

Bandinelli F, Terenzi R, Giovannini L, Milla M, Genise S, Bagnoli S, Biagini S, Annese V, Matucci-Cerinic M.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6):949-52. Epub 2014 Aug 15.

PMID:
25152017
20.

Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease.

Karmiris K, Avgerinos A, Tavernaraki A, Zeglinas C, Karatzas P, Koukouratos T, Oikonomou KA, Kostas A, Zampeli E, Papadopoulos V, Theodoropoulou A, Viazis N, Polymeros D, Michopoulos S, Bamias G, Kapsoritakis A, Karamanolis DG, Mantzaris GJ, Tzathas C, Koutroubakis IE.

J Crohns Colitis. 2016 Apr;10(4):429-36. doi: 10.1093/ecco-jcc/jjv232. Epub 2015 Dec 30.

Supplemental Content

Support Center